CMXHF Projected Dividend Yield
Ord/CSL Ltd ( OTCBB : CMXHF )CSL is engaged in the research, development, manufacture, marketing and distribution of biopharmaceutical products and vaccines. Co.'s operating segments are: CSL Behring and CSL Seqirus. Co.'s CSL Behring segment manufactures, markets, and distributes plasma therapies (plasma products and recombinants), conducts early-stage research on plasma and non-plasma therapies, excluding influenza, and focuses on the commercialization of intellectual property. Co.'s CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products and develops influenza related products. 25 YEAR PERFORMANCE RESULTS |
CMXHF Dividend History Detail CMXHF Dividend News CMXHF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
2024 |
N/A |
N/A |
Sep 10, 2024 |
Oct 02, 2024 |
1.4500 |
2024 |
N/A |
N/A |
Mar 12, 2024 |
Apr 03, 2024 |
1.1900 |
2024 |
N/A |
N/A |
Mar 12, 2024 |
Apr 03, 2024 |
1.1900 |
2024 Total: |
3.8300 |
||||
2023 |
N/A |
N/A |
Sep 12, 2023 |
Oct 04, 2023 |
1.2900 |
2023 |
N/A |
N/A |
Mar 10, 2023 |
Apr 05, 2023 |
1.0700 |
2023 Total: |
2.3600 |
||||
2022 |
N/A |
N/A |
Sep 07, 2022 |
Oct 05, 2022 |
1.1800 |
2022 |
N/A |
N/A |
Mar 08, 2022 |
Apr 06, 2022 |
1.0400 |
2022 Total: |
2.2200 |
||||
2021 |
N/A |
N/A |
Sep 03, 2021 |
Sep 30, 2021 |
1.1800 |
2021 |
N/A |
N/A |
Mar 05, 2021 |
Apr 01, 2021 |
1.0400 |
2021 Total: |
2.2200 |
||||
2020 |
N/A |
N/A |
Sep 11, 2020 |
Oct 09, 2020 |
1.0700 |
2020 |
N/A |
N/A |
Mar 12, 2020 |
Apr 09, 2020 |
0.9167 |
2020 Total: |
1.9867 |
||||
2019 |
N/A |
N/A |
Sep 11, 2019 |
Oct 11, 2019 |
0.9894 |
2019 |
N/A |
N/A |
Mar 14, 2019 |
Apr 12, 2019 |
0.8627 |
2019 Total: |
1.8521 |